Inguinal hernia medical therapy

Jump to navigation Jump to search

Inguinal hernia Microchapters


Patient Information


Historical Perspective




Differentiating Inguinal hernia from other Diseases

Epidemiology and Demographics

Risk Factors


Natural History, Complications and Prognosis


Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray




Other Imaging Findings

Other Diagnostic Studies


Medical Therapy


Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Inguinal hernia medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides


American Roentgen Ray Society Images of Inguinal hernia medical therapy

All Images
Echo & Ultrasound
CT Images

Ongoing Trials at Clinical

US National Guidelines Clearinghouse

NICE Guidance

FDA on Inguinal hernia medical therapy

CDC on Inguinal hernia medical therapy

Inguinal hernia medical therapy in the news

Blogs on Inguinal hernia medical therapy

Directions to Hospitals Treating Inguinal hernia

Risk calculators and risk factors for Inguinal hernia medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]


Pharmacologic medical therapies for inguinal hernia include pain reliever, antibiotics, topical medications.

Medical Therapy

  • Pharmacologic medical therapies for patients with post-operative repair of inguinal hernia include:[1][2][3][4]
    • 1. Pain reliever
    • 2. Antibiotics
      • Preferred regimen: Cefazolin 2 g IV for 7 days
      • Alternative regimen (1): Clindamycin 900 mg q 8h for 7 days
      • Alternative regimen (2): Vancomycin 15 mg/kg IV for 7-10 days
      • Alternative regimen (3): Ciprofloxacin 400 mg IV for 10 days
      • Alternative regimen (4): levofloxacin 500 mg IV for 5 days
      • Alternative regimen (5): Aztreonam 2 g IV q 6-8h (not to exceed 8g/day)
    • 3. Topical medications


  1. Bjurstrom MF, Nicol AL, Amid PK, Chen DC (2014). "Pain control following inguinal herniorrhaphy: current perspectives". J Pain Res. 7: 277–90. doi:10.2147/JPR.S47005. PMC 4045265. PMID 24920934.
  2. Cohen SP, Galvagno SM, Plunkett A, Harris D, Kurihara C, Turabi A, Rehrig S, Buckenmaier CC, Chelly JE (2013). "A multicenter, randomized, controlled study evaluating preventive etanercept on postoperative pain after inguinal hernia repair". Anesth. Analg. 116 (2): 455–62. doi:10.1213/ANE.0b013e318273f71c. PMID 23302973.
  3. Derry S, Sven-Rice A, Cole P, Tan T, Moore RA (2013). "Topical capsaicin (high concentration) for chronic neuropathic pain in adults". Cochrane Database Syst Rev (2): CD007393. doi:10.1002/14651858.CD007393.pub3. PMID 23450576.
  4. O'Connor AB, Dworkin RH (2009). "Treatment of neuropathic pain: an overview of recent guidelines". Am. J. Med. 122 (10 Suppl): S22–32. doi:10.1016/j.amjmed.2009.04.007. PMID 19801049.

Template:WH Template:WS